EUVIMEDEUVIMED entdecken
Crossref

Deubiquitinase USP47 attenuates virus-induced type I interferon signaling

Hong-Yan Chen, Rong-Chun Tang, Jia-Wei Liang, Weijia Zhao, Shuang-Shuang Yu, Ran-Ran Yao, Rui Xu, Ao Zhang, Shijin Geng, Xiu-Yuan Sun, Qing Ge, Jun Zhang

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Hong-Yan Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology(Peking University), Peking University Health Sci…. Hauptthemen laut MEDLINE: Interferon Type I, Viruses. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innate immune responses are tightly regulated to ensure effective clearance of invading pathogens and avoid excessive inflammation. Ubiquitination and deubiquitination are important post-translational modifications in antiviral immune responses. Here, we discovered deubiquitinase USP47 as a novel negative immune system regulator. Overexpression of USP47 repressed Sendai virus, poly(I:C) and poly(dA:dT)-induced ISRE and IFN-β activation, along with reduced IFNB1 transcription and enhanced viral replication. Knockdown of USP47 expression had the opposite effects. Dual-luciferase and phosphorylation assays showed that USP47 targeted downstream of MAVS and upstream of TBK1. Additional co-immunoprecipitation assays suggested that USP47 interacted with TRAF3 and TRAF6. Importantly, USP47 removed K63-linked polyubiquitin chains from TRAF3 and TRAF6. Hence, we describe a novel modulator of the antiviral innate immune response, USP47, which removes K63-linked polyubiquitins from TRAF3 and TRAF6, leading to reduced type I IFN signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type IVirusesTNF Receptor-Associated Factor 3TNF Receptor-Associated Factor 6Immunity, InnateAntiviral AgentsUbiquitinationDeubiquitinating Enzymes

Stichwörter der Autor:innen

DeubiquitinationInnate immunityTRAF3TRAF6USP47type I IFN

Substanzen

TNF Receptor-Associated Factor 3TNF Receptor-Associated Factor 6Interferon Type IAntiviral AgentsDeubiquitinating Enzymes

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology(Peking University), Peking University Health Science Center, Beijing 100191, China.
  • Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology(Peking University), Peking University Health Science Center, Beijing 100191, China. Electronic address: junzhang@bjmu.…

Förderung

  • National Natural Science Foundation of China
  • Peking University
  • Chinese Academy of Sciences
  • Wuhan University

Zitieren

APA

Chen, H. Y., Tang, R. C., Liang, J. W., Zhao, W., Yu, S. S., Yao, R. R., Xu, R., Zhang, A., Geng, S., Sun, X. Y., Ge, Q., & Zhang, J. (2023). Deubiquitinase USP47 attenuates virus-induced type I interferon signaling. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110040

Vancouver

Chen HY, Tang RC, Liang JW, Zhao W, Yu SS, Yao RR, et al. Deubiquitinase USP47 attenuates virus-induced type I interferon signaling. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110040

BibTeX
@article{Chen2023,
  author = {Chen, Hong-Yan and Tang, Rong-Chun and Liang, Jia-Wei and Zhao, Weijia and Yu, Shuang-Shuang and Yao, Ran-Ran and Xu, Rui and Zhang, Ao and Geng, Shijin and Sun, Xiu-Yuan and Ge, Qing and Zhang, Jun},
  title = {Deubiquitinase USP47 attenuates virus-induced type I interferon signaling},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110040}
}
Kostenlos starten →